V5 surfaces only what QA needs to see — missing signatures, out-of-spec readings, deviations, skipped steps — instead of forcing a page-by-page review of every batch. The clean batches release in minutes; the exceptions get the attention they deserve.
A 40-page batch record reviewed line by line costs 2–4 hours of senior QA time — every batch, every day.
When everything looks the same, the missing initials and the OOS reading slip through to release — and the FDA finds them.
Paper review queues build up over the weekend; product sits in quarantine costing working capital and customer service-levels.
V5 only puts a batch in front of QA when something needs attention: missing signature, OOS, deviation, skipped step, out-of-sequence event. Clean batches auto-route for release.
Each flagged item opens with the rule it broke, the evidence (scan, e-signature, sensor reading), and the linked deviation/CAPA in one pane.
QA reviews the exception, applies the disposition, and Part 11-compliant e-signs the release — without leaving the screen.
Every review action — open, comment, accept, reject, escalate — is captured with user, time and reason in the immutable Part 11 trail.
An FDA- and EMA-endorsed model where only batches with exceptions (missing data, OOS, deviation, skipped step) are routed for full QA review. Clean batches release automatically against pre-approved rules in the MBR.
Yes — provided the exception-detection rules are documented in the validated MBR, the exception list is reviewed and signed by QA, and the audit trail captures every decision. V5 enforces all three.
Most sites move from paper batch review to exception review in 7–14 days once the MBR is digitised.
Free trial, no card. Live in 7 days with guided onboarding.